<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JKMS</journal-id>
      <journal-title-group>
        <journal-title>Journal of Korean Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1011-8934</issn>
      <issn pub-type="epub">1598-6357</issn>
      <publisher>
        <publisher-name>The Korean Academy of Medical Sciences</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22065912</article-id>
      <article-id pub-id-type="pmc">3207059</article-id>
      <article-id pub-id-type="doi">10.3346/jkms.2011.26.11.1518</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
          <subj-group>
            <subject>Ophthalmology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Recurrent Bilateral Branch Retinal Artery Occlusion with Hearing Loss and Encephalopathy: The First Case Report of Susac Syndrome in Korea</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Joe</surname>
            <given-names>Soo Geun</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>June-Gone</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kwon</surname>
            <given-names>Sun Uck</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Choong Wook</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lim</surname>
            <given-names>Hyun Woo</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Yoon</surname>
            <given-names>Young Hee</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Ophthalmology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Neurology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea.</aff>
      <aff id="A3"><label>3</label>Department of Radiology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea.</aff>
      <aff id="A4"><label>4</label>Department of Otolaryngology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>
Address for Correspondence: Young Hee Yoon, MD. Department of Ophthalmology, Asan Medical Center, University of Ulsan, College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea. Tel: +82.2-3010-3675, Fax: +82.2-470-6440, <email>yhyoon@amc.seoul.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>10</month>
        <year>2011</year>
      </pub-date>
      <volume>26</volume>
      <issue>11</issue>
      <fpage>1518</fpage>
      <lpage>1521</lpage>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>7</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>9</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2011 The Korean Academy of Medical Sciences.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We report the first case of Susac syndrome in Koreans, in a 23-yr-old female patient who presented with sudden visual loss and associated neurological symptoms. Ophthalmic examination and fluorescein angiography showed multiple areas of branch retinal artery occlusion, which tended to recur in both eyes. Magnetic resonance imaging showed dot-like, diffusion-restricted lesions in the corpus callosum and left fornix, and audiometry showed low-frequency sensory hearing loss, compatible with Susac syndrome. She received immunosuppressive therapy with oral steroid and azathioprine. Three months later all the symptoms disappeared but obstructive vasculitis have been relapsing. This patient demonstrated the entire clinical triad of Susac syndrome, which tends to occur in young females. Although this disorder has rarely been reported in Asian populations, a high index of suspicion is warranted for early diagnosis and timely treatment.</p>
      </abstract>
      <kwd-group>
        <kwd>Susac Syndrome</kwd>
        <kwd>Korean</kwd>
        <kwd>Branch Retinal Artery Occlusion</kwd>
        <kwd>Hearing Loss</kwd>
        <kwd>Encephalopathy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Susac syndrome (SS) consists of the clinical triad of encephalopathy, branch retinal artery obstruction (BRAO) and hearing loss without prominent systemic manifestations (<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B4">4</xref>). It is thought to be caused by pre-capillary arteriole obstruction of the brain, retina and inner ear due to damage from circulating anti-endothelial cell antibodies (<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B5">5</xref>). These symptoms may not always occur, and disease presentation is often insidious (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B6">6</xref>), such that patients with initial presenting symptoms may be misdiagnosed. Although many patients with SS have been reported in Western countries, none has yet been reported in Korea.</p>
    </sec>
    <sec>
      <title>CASE DESCRIPTION</title>
      <p>A 23-yr-old woman visited the emergency clinic on November 23, 2011 with visual disturbance and a visual field defect in her left eye which had developed 1 day earlier. She had started to experience recurrent visual field defects in both eyes and headache 6 months earlier, and these symptoms became aggravated 1 month earlier. She denied having diabetes, hypertension, connective tissue disease, tuberculosis, hematologic disease or cardiovascular disease. She also stated that she had not used oral contraceptives and was not pregnant.</p>
      <p>On initial examination, her pupils were reactive to light without relative afferent papillary defect. Corrected visual acuity was 20/20 in her right eye and 20/25 in her left eye. IOP was 18 mmHg in both eyes. Slit lamp examination revealed no abnormal findings in the anterior segment of both eyes. Fundoscopic examination showed an edematous lesion in the supra-temporal area of her left eye (<xref ref-type="fig" rid="F1">Fig. 1A</xref>), and normal findings in her right eye. Fluorescein angiography (FA) revealed obstructive vasculitis in the supra-temporal branch of the retinal artery in her left eye (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). A visual field test showed an infra-nasal field defect in her left eye and a small field defect in her right eye (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p>
      <p>Two days later, the patient again visited the emergency clinic due to sudden hearing loss in her left ear, which had developed that morning. Pure tone audiometry showed sensory neuronal hearing loss at low-frequency in her left ear (<xref ref-type="fig" rid="F3">Fig. 3</xref>). Three weeks later, she complained of a visual field defect in her right eye. A repeat FA showed BRAO in her right eye, but the signs of obstructive vasculitis in her left eye had disappeared. Two days later, she was admitted to the neurologic ward for tinnitus and severe headache with arm numbness.</p>
      <p>Laboratory tests, including for lupus anticoagulant, anticardiolipin antibody, erythrocyte sedimentation rate, and C-reactive protein, were all normal. Cerebrospinal fluid (CSF) analysis showed a slight increase in protein concentration (74.4 mg/dL), without evidence of oligoclonal bands. There were no specific hematologic or rheumatologic abnormalities. Magnetic resonance (MR) imaging showed dot-like, diffusion-restricted lesions with T2 signal change in the corpus callosum and left fornix (<xref ref-type="fig" rid="F4">Fig. 4A, B</xref>).</p>
      <p>After considering all these findings, she was diagnosed with SS and started on high dose steroid therapy. Two months later, FA detected newly developed occlusive vasculitis in both eyes (<xref ref-type="fig" rid="F5">Fig. 5</xref>). Follow-up sagittal Fluid-attenuated inversion recovery (FLAIR) MR imaging showed a signal change in the area corresponding to that of the previous infarction in the corpus callosum (<xref ref-type="fig" rid="F4">Fig. 4C</xref>), but there was no evidence of newly developed ischemic brain lesions. The dosage of oral steroids was maintained, and azathioprine (50 mg bid) was added. Three months later, her symptoms of headache, tinnitus and visual field defect had all resolved. However, FA showed new vasculitis and obstruction of the branch retinal artery, although all previously affected lesions had normalized.</p>
    </sec>
    <sec>
      <title>DISCUSSION</title>
      <p>We have described here a young female patient who showed the clinical triad of SS: BRAO, hearing loss and encephalopathy. To our knowledge, this is the first case report of SS in Korea. Since the first description of SS in 1977, hundreds of patients with SS have been reported, mainly in Western countries (<xref ref-type="bibr" rid="B3">3</xref>). Women are more frequently affected than men, with young white women between the age of 20 and 40 yr being most susceptible (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B6">6</xref>). A MEDLINE search for SS in Asian populations showed only one case report, in a Japanese male (<xref ref-type="bibr" rid="B1">1</xref>).</p>
      <p>Retinal arterial occlusion is rare in younger individuals (<xref ref-type="bibr" rid="B7">7</xref>), with nearly 75% of these patients being older individuals with retinal arterial occlusion caused by embolization of atheromatous plaques of the carotid artery (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). Retinal arterial occlusion in younger patients is usually due to migraine, a coagulation abnormality, cardiac disease, trauma, drug abuse or connective tissue disease (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B9">9</xref>). In patients with SS, localized retinal vasculitis rather than embolism is believed to cause arteriolar occlusions, which usually do not occur at bifurcations (<xref ref-type="bibr" rid="B10">10</xref>). BRAO tends to be bilateral, and to be multiple, widely disseminated in the retina, and temporally separated by as long as several months. The white material in the arterial lumen may represent aggregations of immune complexes or debris from damaged endothelium (<xref ref-type="bibr" rid="B11">11</xref>). A characteristic feature on FA is arterial wall hyperfluorescence, often proximal to sites of occlusion, as shown in our patient, and suggesting endothelial dysfunction (<xref ref-type="bibr" rid="B11">11</xref>).</p>
      <p>Common neurological features of SS include severe headache, which may occur several months prior to other symptoms, and personality disorder (<xref ref-type="bibr" rid="B12">12</xref>). Due to the multifocal vasculitis, neurological manifestations are extremely variable and include ataxia, vertigo, corticospinal tract signs, and even seizure. On MRI, microinfarcts are best seen on T2 weighted images as hyperintense lesions (<xref ref-type="bibr" rid="B13">13</xref>). These microinfarcts are usually multifocal and located in the area of the corpus callosum, as seen in our patient (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). CSF may contain a normal or high protein concentration. High protein concentration, coupled with an absence of oligoclonal bands, is typical, as in our patient (<xref ref-type="bibr" rid="B14">14</xref>).</p>
      <p>Characteristic audiological findings in SS include low-frequency hearing loss, vertigo, and tinnitus. Our patient had both low-frequency hearing loss and tinnitus, which were likely due to microangiopathic lesions of the apical cochlea end arterioles (<xref ref-type="bibr" rid="B2">2</xref>).</p>
      <p>The diagnosis of SS is often difficult because its characteristic signs often do not occur simultaneously or may be too subtle for the patient to notice (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B15">15</xref>). In one case report, the patient presented with encephalopathy 10 yr before hearing loss, with recurrence of encephalopathy 18 yr later (<xref ref-type="bibr" rid="B2">2</xref>). Another patient experienced multiple BRAO episodes over 30 yr, followed by a Swiss-cheese like corpus callosum on MR imaging without signs of encephalopathy (<xref ref-type="bibr" rid="B1">1</xref>). Therefore, patients who manifest one of the clinical signs of SS should be suspected of this disorder. Although SS has been considered rare, it may be more common than reported (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>).</p>
      <p>As in many other autoimmune diseases, steroid therapy is the mainstay of treatment for SS (<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref>). Initial high dose corticosteroid therapy, followed by tapering, has been recommended (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B4">4</xref>). Additional immune suppressive treatment, with cyclophosphamide, mycophenolate mofetil, methotrexate, or cyclosporine, may be helpful (<xref ref-type="bibr" rid="B2">2</xref>). Many patients have improved after receiving intravenous immunoglobulin (<xref ref-type="bibr" rid="B2">2</xref>).</p>
      <p>To avoid disastrous consequences, aggressive and timely treatment is needed, for a sufficient period of time (<xref ref-type="bibr" rid="B2">2</xref>). However, progression of SS may be insidious and the symptoms do not always occur together.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murata</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Inada</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Negi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Susac syndrome</article-title>
          <source>Am J Ophthalmol</source>
          <year>2000</year>
          <volume>129</volume>
          <fpage>682</fpage>
          <lpage>684</lpage>
          <pub-id pub-id-type="pmid">10844072</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rennebohm</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Egan</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Susac</surname>
              <given-names>JO</given-names>
            </name>
          </person-group>
          <article-title>Treatment of Susac's syndrome</article-title>
          <source>Curr Treat Options Neurol</source>
          <year>2008</year>
          <volume>10</volume>
          <fpage>67</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="pmid">18325301</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Susac</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Egan</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Rennebohm</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Lubow</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Susac's syndrome: 1975-2005 microangiopathy/autoimmune endotheliopathy</article-title>
          <source>J Neurol Sci</source>
          <year>2007</year>
          <volume>257</volume>
          <fpage>270</fpage>
          <lpage>272</lpage>
          <pub-id pub-id-type="pmid">17331544</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rennebohm</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Susac</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Egan</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Daroff</surname>
              <given-names>RB</given-names>
            </name>
          </person-group>
          <article-title>Susac's syndrome: update</article-title>
          <source>J Neurol Sci</source>
          <year>2010</year>
          <volume>299</volume>
          <fpage>86</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">20855088</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jarius</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Neumayer</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wandinger</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Hartmann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wildemann</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Anti-endothelial serum antibodies in a patient with Susac's syndrome</article-title>
          <source>J Neurol Sci</source>
          <year>2009</year>
          <volume>285</volume>
          <fpage>259</fpage>
          <lpage>261</lpage>
          <pub-id pub-id-type="pmid">19643446</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martinet</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fardeau</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Adam</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bodaghi</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Papo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Piette</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Lehoang</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Fluorescein and indocyanine green angiographies in Susac syndrome</article-title>
          <source>Retina</source>
          <year>2007</year>
          <volume>27</volume>
          <fpage>1238</fpage>
          <lpage>1242</lpage>
          <pub-id pub-id-type="pmid">18046231</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trevino</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pearlman</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Idiopathic recurrent branch retinal arterial occlusion in a young adult</article-title>
          <source>Optom Vis Sci</source>
          <year>1998</year>
          <volume>75</volume>
          <fpage>11</fpage>
          <lpage>16</lpage>
          <pub-id pub-id-type="pmid">9460781</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beatty</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Au Eong</surname>
              <given-names>KG</given-names>
            </name>
          </person-group>
          <article-title>Acute occlusion of the retinal arteries: current concepts and recent advances in diagnosis and management</article-title>
          <source>J Accid Emerg Med</source>
          <year>2000</year>
          <volume>17</volume>
          <fpage>324</fpage>
          <lpage>329</lpage>
          <pub-id pub-id-type="pmid">11005400</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Recchia</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>GC</given-names>
            </name>
          </person-group>
          <article-title>Systemic disorders associated with retinal vascular occlusion</article-title>
          <source>Curr Opin Ophthalmol</source>
          <year>2000</year>
          <volume>11</volume>
          <fpage>462</fpage>
          <lpage>467</lpage>
          <pub-id pub-id-type="pmid">11141642</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gass</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Tiedeman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Idiopathic recurrent branch retinal arterial occlusion</article-title>
          <source>Ophthalmology</source>
          <year>1986</year>
          <volume>93</volume>
          <fpage>1148</fpage>
          <lpage>1157</lpage>
          <pub-id pub-id-type="pmid">3808626</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Notis</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Kitei</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Cafferty</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Odel</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Microangiopathy of brain, retina, and inner ear</article-title>
          <source>J Neuroophthalmol</source>
          <year>1995</year>
          <volume>15</volume>
          <fpage>1</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">7780564</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Susac</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Hardman</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Selhorst</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Microangiopathy of the brain and retina</article-title>
          <source>Neurology</source>
          <year>1979</year>
          <volume>29</volume>
          <fpage>313</fpage>
          <lpage>316</lpage>
          <pub-id pub-id-type="pmid">571975</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O'Halloran</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Pearson</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Susac</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Microangiopathy of the brain, retina, and cochlea (Susac syndrome). A report of five cases and a review of the literature</article-title>
          <source>Ophthalmology</source>
          <year>1998</year>
          <volume>105</volume>
          <fpage>1038</fpage>
          <lpage>1044</lpage>
          <pub-id pub-id-type="pmid">9627654</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Susac</surname>
              <given-names>JO</given-names>
            </name>
          </person-group>
          <article-title>Susac's syndrome: the triad of microangiopathy of the brain and retina with hearing loss in young women</article-title>
          <source>Neurology</source>
          <year>1994</year>
          <volume>44</volume>
          <fpage>591</fpage>
          <lpage>593</lpage>
          <pub-id pub-id-type="pmid">8164809</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D&#xF6;rr</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Radbruch</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bock</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wuerfel</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bruggemann</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wandinger</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Zeise</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pfueller</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Zipp</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Paul</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Encephalopathy, visual disturbance and hearing loss-recognizing the symptoms of Susac syndrome</article-title>
          <source>Nat Rev Neurol</source>
          <year>2009</year>
          <volume>5</volume>
          <fpage>683</fpage>
          <lpage>688</lpage>
          <pub-id pub-id-type="pmid">19953118</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>Fundus photo showing edematous lesions in the supra-temporal area (<bold>A</bold>). Fluorescein angiography, showing a hyperfluorescent arterial wall proximal to the obstructed branch retinal artery (<bold>B</bold>).</p>
      </caption>
      <graphic xlink:href="jkms-26-1518-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Fig. 2</label>
      <caption>
        <p>Visual field test results, showing an infranasal field defect of the left eye corresponding to the obstructed lesion and a small area of visual field defect in the right eye.</p>
      </caption>
      <graphic xlink:href="jkms-26-1518-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Fig. 3</label>
      <caption>
        <p>Pure tone audiometry, showing decreased sensitivity to low-frequency sounds in the left ear.</p>
      </caption>
      <graphic xlink:href="jkms-26-1518-g003"/>
    </fig>
    <fig id="F4" position="float">
      <label>Fig. 4</label>
      <caption>
        <p>Magnetic resonance image of the brain. (<bold>A</bold>, <bold>B</bold>) Diffusion weighted images, showing a diffusion restricted lesion in the corpus callosum and left fornix. (<bold>C</bold>) Sagittal Fluid-attenuated inversion recovery (FLAIR) image showing a focal signal change in the corpus callosum.</p>
      </caption>
      <graphic xlink:href="jkms-26-1518-g004"/>
    </fig>
    <fig id="F5" position="float">
      <label>Fig. 5</label>
      <caption>
        <p>Fluorescein angiography showing hyperfluorescent vasculitis lesions (arrows) (<bold>A</bold>-<bold>D</bold>) and an obstructed branch retinal artery (arrowheads) (<bold>D</bold>).</p>
      </caption>
      <graphic xlink:href="jkms-26-1518-g005"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
